EP Patent

EP3468606A1 — A novel pharmaceutical composition of a lipid lowering compound

Assigned to Liqmeds Ltd · Expires 2019-04-17 · 7y expired

What this patent protects

The present invention provides liquid oral dosage form of lipid lowering agent suitable for oral administration to human or animals.

USPTO Abstract

The present invention provides liquid oral dosage form of lipid lowering agent suitable for oral administration to human or animals.

Drugs covered by this patent

Lipitor (Atorvastatin Calcium) · Pfizer

Patent Metadata

Patent number: EP3468606A1
Jurisdiction: EP
Classification: —
Expires: 2019-04-17
Drug substance claim: No
Drug product claim: No
Assignee: Liqmeds Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.